NOVOZYMES NORTH AMERICA, INC. — Lobbying Disclosure | Poliscope

NOVOZYMES NORTH AMERICA, INC.

View full entity profile (contributions, contracts, SEC) →

This entity appears on both sides of lobbying disclosures. The firm tab shows registrant-reported income; the client tab shows client-reported lobbying spend. Contract awards are separate and are not included here.

Lobbying Spend

$9.1M

Filings

176

Firms Hired

Active Period

2006–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	$470,000	7	3
2025	$780,000	11	3
2024	$540,000	8	2
2023	$960,000	14	4
2022	$610,000	14	4
2021	$430,000	12	3
2020	$610,000	14	3
2019	$470,000	4	1
2018	$410,000	4	1
2017	$440,000	4	1
2016	$460,000	4	1
2015	$340,000	4	1
2014	$240,000	7	2
2013	$370,000	10	2
2012	$390,284	11	2
2011	$248,123	8	2
2010	$480,000	13	3
2009	$490,000	12	3
2008	$410,000	11	2
2007	—	2	1
2006	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
NOVOZYMES NORTH AMERICA, INC.	$9,148,406	83
THE RUSSELL GROUP, INC.	—	28
PRIME POLICY GROUP	—	20
DICKSTEIN SHAPIRO LLP	—	17
BOUNDARY STONE PARTNERS	—	5
ATLAS CROSSING LLC	—	6
JEFFREY J. KIMBELL & ASSOCIATES, INC.	—	13
BKSH & ASSOCIATES	—	4

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	151
SENATE	151
Agriculture, Dept of (USDA)	66
Environmental Protection Agency (EPA)	55
Energy, Dept of	22
White House Office	17
Office of Management & Budget (OMB)	12
Office of Science & Technology Policy (OSTP)	7
Commerce, Dept of (DOC)	4
Food & Drug Administration (FDA)	4
State, Dept of (DOS)	4
U.S. Trade Representative (USTR)	3
Interior, Dept of (DOI)	2
Natl Economic Council (NEC)	2
Treasury, Dept of	2
Executive Office of the President (EOP)	1
Small Business Administration (SBA)	1
Transportation, Dept of (DOT)	1
U.S. Customs & Border Protection	1

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Agriculture	Agriculture	109
Energy/Nuclear	Energy/Nuclear	82
Environment/Superfund	Environment/Superfund	56
Budget/Appropriations	Budget/Appropriations	42
Taxation/Internal Revenue Code	Taxation/Internal Revenue Code	26
Transportation	Transportation	24
Health Issues	Health Issues	19
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	11
Defense	Defense	9
Chemicals/Chemical Industry	Chemicals/Chemical Industry	7
Animals	Animals	6
Natural Resources	Natural Resources	6
Trade (domestic/foreign)	Trade (domestic/foreign)	4
Labor Issues/Antitrust/Workplace	Labor Issues/Antitrust/Workplace	3
Fuel/Gas/Oil	Fuel/Gas/Oil	2
Copyright/Patent/Trademark	Copyright/Patent/Trademark	1
Clean Air and Water (quality)	Clean Air and Water (quality)	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 2756119th Congress

National Biotechnology Initiative Act of 2025

2026 · third_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to nutrition and Generally Recognized as Safe (GRAS) requirements, including FDA regulation of food and feed ingredients, GRAS modernization, national uniformity; issues pertaining to biotechnology, including H.R. 2756, the National Biotechnology Initiative Act of 2025; and issues related to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act.

Client expense: $110,000 · Firm income: —

Matched citations: H.R. 2756

H.R. 7366119th Congress

Dietary Supplement Regulatory Uniformity Act

2026 · third_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to nutrition and Generally Recognized as Safe (GRAS) requirements, including FDA regulation of food and feed ingredients, GRAS modernization, national uniformity; issues pertaining to biotechnology, including H.R. 2756, the National Biotechnology Initiative Act of 2025; and issues related to dietary supplements, including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act.

Client expense: $110,000 · Firm income: —

Matched citations: H.R. 7366

H.R. 4794118th Congress

Dietary Supplements Access Act

2026 · third_quarter · Firm: ATLAS CROSSING LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the expansion of HSA for dietary supplements. Issues related to the benefits of dietary supplements. Issues related to the Generally Recognized as Safe designation. H.R.4794/S.3172 - Dietary Supplements Access Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R.4794

S. 3172119th Congress

A bill to repeal certain Acts that impose sanctions upon Syria.

2026 · third_quarter · Firm: ATLAS CROSSING LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the expansion of HSA for dietary supplements. Issues related to the benefits of dietary supplements. Issues related to the Generally Recognized as Safe designation. H.R.4794/S.3172 - Dietary Supplements Access Act.

Client expense: — · Firm income: $50,000

Matched citations: S.3172

Show 21 more cited filings

H.R. 2756119th Congress

National Biotechnology Initiative Act of 2025

2026 · second_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to sustainability, animal feed additives, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, biological products in agriculture, biotechnology and biological products, including the National Biotechnology Initiative Act of 2025 (H.R. 2756/S. 1387), and issues related to dietary supplements including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to nutrition, FDA regulation of feed ingredients, and agricultural biotechnology.

Client expense: $140,000 · Firm income: —

Matched citations: H.R. 2756

H.R. 7366119th Congress

Dietary Supplement Regulatory Uniformity Act

2026 · second_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to sustainability, animal feed additives, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, biological products in agriculture, biotechnology and biological products, including the National Biotechnology Initiative Act of 2025 (H.R. 2756/S. 1387), and issues related to dietary supplements including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to nutrition, FDA regulation of feed ingredients, and agricultural biotechnology.

Client expense: $140,000 · Firm income: —

Matched citations: H.R. 7366

S. 1387119th Congress

National Biotechnology Initiative Act of 2025

2026 · second_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to sustainability, animal feed additives, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, biological products in agriculture, biotechnology and biological products, including the National Biotechnology Initiative Act of 2025 (H.R. 2756/S. 1387), and issues related to dietary supplements including H.R. 7366, the Dietary Supplement Regulatory Uniformity Act. Issues related to nutrition, FDA regulation of feed ingredients, and agricultural biotechnology.

Client expense: $140,000 · Firm income: —

Matched citations: S. 1387

H.R. 4794118th Congress

Dietary Supplements Access Act

2026 · second_quarter · Firm: ATLAS CROSSING LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the expansion of HSA for dietary supplements. Issues related to the benefits of dietary supplements. Issues related to the Generally Recognized as Safe designation. H.R.4794/S.3172 - Dietary Supplements Access Act.

Client expense: — · Firm income: $50,000

Matched citations: H.R.4794

S. 3172119th Congress

A bill to repeal certain Acts that impose sanctions upon Syria.

2026 · second_quarter · Firm: ATLAS CROSSING LLC

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the expansion of HSA for dietary supplements. Issues related to the benefits of dietary supplements. Issues related to the Generally Recognized as Safe designation. H.R.4794/S.3172 - Dietary Supplements Access Act.

Client expense: — · Firm income: $50,000

Matched citations: S.3172

H.R. 2756119th Congress

National Biotechnology Initiative Act of 2025

2026 · first_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to sustainability - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. H.R. 7366 - Dietary Supplement Regulatory Uniformity Act - Issues related to dietary supplements.

Client expense: $220,000 · Firm income: —

Matched citations: H.R.2756

H.R. 7366119th Congress

Dietary Supplement Regulatory Uniformity Act

2026 · first_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to sustainability - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. H.R. 7366 - Dietary Supplement Regulatory Uniformity Act - Issues related to dietary supplements.

Client expense: $220,000 · Firm income: —

Matched citations: H.R. 7366

S. 1387119th Congress

National Biotechnology Initiative Act of 2025

2026 · first_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to sustainability - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. H.R. 7366 - Dietary Supplement Regulatory Uniformity Act - Issues related to dietary supplements.

Client expense: $220,000 · Firm income: —

Matched citations: S.1387

H.R. 2756119th Congress

National Biotechnology Initiative Act of 2025

2025 · fourth_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to sustainability - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. Issues related to dietary supplements - no specific legislation.

Client expense: $150,000 · Firm income: —

Matched citations: H.R.2756

S. 1387119th Congress

National Biotechnology Initiative Act of 2025

2025 · fourth_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to sustainability - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to biotechnology and biological products including H.R.2756/S.1387 - National Biotechnology Initiative Act of 2025. Issues related to dietary supplements - no specific legislation.

Client expense: $150,000 · Firm income: —

Matched citations: S.1387

H.R. 1346119th Congress

To amend the Clean Air Act with respect to the ethanol waiver for Reid Vapor Pressure under that Act, and for other purposes.

2025 · third_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to biotechnology and biological products including H.R.2756 - National Biotechnology Initiative Act of 2025. H.R. 1346/S. 593 - Nationwide Consumer and Fuel Retailer Choice Act of 2025 and H.R. 4864/S. 2591 - Ethanol for America Act of 2025 - Issues related to biofuels industry expansion.

Client expense: $210,000 · Firm income: —

Matched citations: H.R. 1346

H.R. 2756119th Congress

National Biotechnology Initiative Act of 2025

2025 · third_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to biotechnology and biological products including H.R.2756 - National Biotechnology Initiative Act of 2025. H.R. 1346/S. 593 - Nationwide Consumer and Fuel Retailer Choice Act of 2025 and H.R. 4864/S. 2591 - Ethanol for America Act of 2025 - Issues related to biofuels industry expansion.

Client expense: $210,000 · Firm income: —

Matched citations: H.R.2756

H.R. 4864119th Congress

Ethanol for America Act of 2025

2025 · third_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to biotechnology and biological products including H.R.2756 - National Biotechnology Initiative Act of 2025. H.R. 1346/S. 593 - Nationwide Consumer and Fuel Retailer Choice Act of 2025 and H.R. 4864/S. 2591 - Ethanol for America Act of 2025 - Issues related to biofuels industry expansion.

Client expense: $210,000 · Firm income: —

Matched citations: H.R. 4864

S. 2591119th Congress

Ethanol for America Act of 2025

2025 · third_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to biotechnology and biological products including H.R.2756 - National Biotechnology Initiative Act of 2025. H.R. 1346/S. 593 - Nationwide Consumer and Fuel Retailer Choice Act of 2025 and H.R. 4864/S. 2591 - Ethanol for America Act of 2025 - Issues related to biofuels industry expansion.

Client expense: $210,000 · Firm income: —

Matched citations: S. 2591

S. 593119th Congress

Nationwide Consumer and Fuel Retailer Choice Act of 2025

2025 · third_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to biotechnology and biological products including H.R.2756 - National Biotechnology Initiative Act of 2025. H.R. 1346/S. 593 - Nationwide Consumer and Fuel Retailer Choice Act of 2025 and H.R. 4864/S. 2591 - Ethanol for America Act of 2025 - Issues related to biofuels industry expansion.

Client expense: $210,000 · Firm income: —

Matched citations: S. 593

H.R. 2756119th Congress

National Biotechnology Initiative Act of 2025

2025 · second_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to sustainability - no specific legislation. Issues related to biotechnology and biological products including H.R.2756 - National Biotechnology Initiative Act of 2025. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. Issues related to funding for Codex Allmentarius (Food Guide) - no specific legislation.

Client expense: $270,000 · Firm income: —

Matched citations: H.R.2756

H.R. 8467118th Congress

Farm, Food, and National Security Act of 2024

2024 · fourth_quarter · Firm: THE RUSSELL GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to gene editing/biotech regulation; issues pertaining to sustainability; issues pertaining to biological solutions; issues related to biofuels; and issues pertaining to H.R. 8467 The Farm, Food, and National Security Act of 2024.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 8467

H.R. 471118th Congress

SHIP IT Act

2024 · fourth_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the Safer Choice Standard - no specific legislation. Issues related to funding for the EPA - no specific legislation. Issues related to renewables fuels and E-15 including S.2707 - Nationwide Consumer and Fuel Retailer Choice Act of 2023 - no specific legislation. H.R.471 SHIP IT Act - entire bill.

Client expense: $120,000 · Firm income: —

Matched citations: H.R.471

H.R. 7130118th Congress

FAIR Labels Act of 2024

2024 · fourth_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to sustainability - no specific legislation. Issues related to biotechnology and biological products - no specific legislation. Issues related to animal feed additives, sustainability, renewable fuels, Generally Recognized as Safe (GRAS) Notification Program, and biological product in agriculture - no specific legislation. H.R. 7130 - FAIR Labels Act of 2024 - entire bill.

Client expense: $120,000 · Firm income: —

Matched citations: H.R. 7130

S. 2707118th Congress

Nationwide Consumer and Fuel Retailer Choice Act of 2023

2024 · fourth_quarter · Firm: NOVOZYMES NORTH AMERICA, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues related to the Safer Choice Standard - no specific legislation. Issues related to funding for the EPA - no specific legislation. Issues related to renewables fuels and E-15 including S.2707 - Nationwide Consumer and Fuel Retailer Choice Act of 2023 - no specific legislation. H.R.471 SHIP IT Act - entire bill.

Client expense: $120,000 · Firm income: —

Matched citations: S.2707

H.R. 8467118th Congress

Farm, Food, and National Security Act of 2024

2024 · third_quarter · Firm: THE RUSSELL GROUP, INC.

Open original LDA filing ↗

Cited source text and reported amounts

Issues pertaining to gene editing/biotech regulation; issues pertaining to sustainability; issues pertaining to biological solutions; issues pertaining to H.R. 8467 The Farm, Food, and National Security Act of 2024.

Client expense: — · Firm income: $50,000

Matched citations: H.R. 8467

Source: Senate LDA